Sthree Pharmaceuticals Private Limited
About Sthree Pharmaceuticals Private Limited
Data last updated:
Sthree Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 August 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24297TN2015PTC101802. Its GSTIN is 33AAWCS1304C1ZO (Tamil Nadu).
The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹6 Cr. It is led by directors including Ayyavu Rajavel and Jayanthy Ayyavu Shanmugam.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Sf No. 534/4A2B Chettinadu Hospital Road Padur, Chennai, Tamil Nadu, India – 603103.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.46 Cr, a decline of 69% compared to the previous year. For the same year it recorded a net profit of ₹37.57 Lakh (net margin 25.7%) and EBITDA of ₹1.23 Cr (EBITDA margin 83.9%). Revenue has grown at a compounded annual rate (CAGR) of 101% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sthree Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address is in the company report.
- Email
- Registered AddressSf No. 534/4A2B Chettinadu Hospital Road Padur, Chennai, Tamil Nadu, India – 603103
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sthree Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sthree Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sthree Pharmaceuticals Private Limited, buy the company report.
Financials of Sthree Pharmaceuticals Private Limited
FY 2024 filings availableSthree Pharmaceuticals Private Limited reported revenue of ₹1.46 Cr (down 69% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 69% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 101%. EBITDA rose 289% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.23 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹37.57 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 83.9% | ||||
| Net Profit Margin | 25.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sthree Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sthree Pharmaceuticals Private Limited
Sthree Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ayyavu Rajavel Also directs: Nuray Chemicals Private Limited, Saimirra Innopharm Private Limited, Esjay Pharma Private Limited and 5 more | Director | 06 Oct 2017 | 9 Years 0 Months | Current |
| Jayanthy Ayyavu Shanmugam Also directs: Annamar Pharma LLP, Sthree Chemicals Private Limited | Director | 06 Oct 2017 | 9 Years 0 Months | Current |
| Shanmugam Muthusamy Also directs: Annamar Pharma LLP, Nuray Chemicals Private Limited, Saimirra Innopharm Private Limited and 5 more | Director | 06 Oct 2017 | 9 Years 0 Months | Current |
| Duraisamy Sengottuvelu Also directs: Annamar Pharma LLP | Director | 13 Aug 2015 | 11 Years 2 Months | Current |
Peer comparison
Sthree Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Strimed Pharmaceuticals Private Limited | ₹1.47 Cr (FY 2025) | 13.0% | Mumbai, Maharashtra, India | |||
| Sthree Pharmaceuticals Private Limitedthis company | ₹1.46 Cr (FY 2024) | ₹37.57 Lakh | 25.7% | -69.0% | Chennai, Tamil Nadu, India | |
| Stevia Pharmaceuticals Private Limited | ₹1.46 Cr (FY 2025) | -8.0% | Secunderabad, Telangana, India | |||
| Helisinki Pharmaceuticals Private Limited | ₹1.46 Cr (FY 2024) | 14.0% | Karnal, Haryana, India |
To see the full peer comparison of Sthree Pharmaceuticals Private Limited, buy the company report.
Auditor
Sthree Pharmaceuticals Private Limited is audited by Essveeyar for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Essveeyar | FY 2022 | 000808S |
Shareholding
The shareholding of Sthree Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sthree Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sthree Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sthree Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sthree Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAWCS1304C1ZO | Tamil Nadu | Active | 09 Jun 2020 |
To see the full GST registrations and return filing status of Sthree Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sthree Pharmaceuticals Private Limited has 5 board changes on record since 2015: 4 appointments and 1 cessation. The latest: Ayyavu Rajavel was appointed as Director on 06 Oct 2017.
Frequently asked questions
Sthree Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 August 2015 (11+ years old) and is registered under CIN U24297TN2015PTC101802.
Sthree Pharmaceuticals has 4 current directors:
- Ayyavu Rajavel - Director
- Jayanthy Ayyavu Shanmugam - Director
- Shanmugam Muthusamy - Director
- Duraisamy Sengottuvelu - Director
The latest financial statements of Sthree Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Sthree Pharmaceuticals is 33AAWCS1304C1ZO, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Sthree Pharmaceuticals is U24297TN2015PTC101802. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sthree Pharmaceuticals was incorporated on 13 August 2015, making it 11+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Sthree Pharmaceuticals by revenue are Strimed Pharmaceuticals Private Limited, Stevia Pharmaceuticals Private Limited, Helisinki Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Ayyavu Rajavel was appointed as Director on 06 Oct 2017. Duraisamy ceased to be Director on 06 Oct 2017. Jayanthy Ayyavu Shanmugam was appointed as Director on 06 Oct 2017. Sthree Pharmaceuticals has 5 board changes on record in total.
The registered office of Sthree Pharmaceuticals is at Sf No. 5344A2B Chettinadu Hospital Road Padur, Chennai, Tamil Nadu, India – 603103.
Sthree Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Sthree Pharmaceuticals is compliant as of 19 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
